而现实生活中由于母体、胎儿及胎盘因素导致的胎儿生长受限（FGR）实难避免。
While in our clinical work, we can often experienced such kind of newborns with fetal growth restriction (FGR) due to the factors of either mother, fetus or placenta.
胎儿和胎盘。胎儿的结局是胎儿宫内生长受限和羊水过少，重度或早发的先兆子痫引起胎儿出生体重最大的减少。
J. Fetus and placenta. The fetal consequences are fetal growth restriction and oligohydramnios. Severe or early onset preeclampsia result in the greatest decrements in birth weight.
对胎盘葡萄糖转运蛋白表达的研究，有助于进一步阐明胎儿生长受限的发生机制，并为其预防和治疗提供新的思路。
The study on expression of glucose transporter in placenta may be helpful to elucidate pathogenesis of fetal growth restriction(FGR), and provide new ideas for prevention and treatment of FGR.
目的探讨胎儿宫内生长受限(FGR)中细胞因子对胎盘细胞凋亡的调节。
Objective to explore the regulation of cytokines to apoptosis in placenta in fetal growth restriction (FGR).
目的：探讨血管内皮生长因子与胎儿生长受限(FGR)的关系。
Objective: to explore the relationship between the level of vascular endothelial growth factor (VEGF) in pregnant women and incidence of fetal growth restriction (FGR).
胎儿生长受限(FGR)是围生期常见的并发症之一，其发病机制复杂，临床上仍然没有很有效的治疗措施。
Fetal growth restriction (FGR) is one of the most common complication in perinatal period, of which the pathogenesis is complex. and there is still no effective therapy in clinic.
与母血清标志物升高有关的不良结局有子痫前期、新生儿窒息、胎儿生长受限、胎儿丢失及胎盘异常。
The high levels of maternal serum markers was significantly associated with preeclampsia, neonatal asphyxia, fetal growth restriction, fetal demise, and abnormal placenta.
与母血清标志物升高有关的不良结局有子痫前期、新生儿窒息、胎儿生长受限、胎儿丢失及胎盘异常。
The high levels of maternal serum markers was significantly associated with preeclampsia, neonatal asphyxia, fetal growth restriction, fetal demise, and abnormal placenta.
应用推荐